Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SYNAGEVA-BIOPHARMA-CORP-11900119/news/Synageva-BioPharma-Completes-Targeted-Enrollment-in-Phase-1-2-Trial-with-SBC-103-for-Mucopolysacch-20492659/?utm_source=whatsapp&utm_medium=social&utm_campaign=share